Rite Aid to close all stores nationwide amid 2nd bankruptcy filing

Rite Aid has ceased all operations, closing its stores nationwide following a second bankruptcy filing in May 2025, just eight months after emerging from a previous Chapter 11. This final closure, driven by persistent financial challenges including declining sales and over 1,000 opioid-related lawsuits, signals the complete wind-down of a major pharmacy chain and highlights the severe pressures within the retail pharmacy sector and the significant impact of litigation on distressed assets.

Analysis

Rite Aid to close all stores nationwide amid 2nd bankruptcy filing The company thanked its loyal customers for their support over the years. Rite Aid has shuttered all of its stores after more than six decades in business. The pharmacy chain made the announcement in a post on its website, stating, "All Rite Aid stores have now closed. We thank our loyal customers for their many years of support.” ABC News has reached out to the company for comment, but did not immediately hear back. Despite its long history in the pharmacy industry, Rite Aid has faced mounting financial challenges in recent years. The company most recently filed for bankruptcy protection in May, just eight months after emerging from a previous Chapter 11 filing in September 2024. At the time, Rite Aid -- which operated more than 1,200 stores across 15 states from California to Vermont -- said it planned to keep stores open while selling off assets to avoid disrupting customers’ prescription services. The company also announced it had secured $1.94 billion in new financing from existing lenders to stay operational during bankruptcy proceedings. Rite Aid had first filed for Chapter 11 bankruptcy in October 2023, allowing it to reduce billions in debt and close hundreds of underperforming stores. Alongside declining sales, the company has also faced more than 1,000 federal, state, and local lawsuits alleging its pharmacies improperly filled prescriptions for painkillers, according to the New York Times. In March 2023, the U.S. Department of Justice filed a complaint accusing Rite Aid of filling "unlawful prescriptions for controlled substances" that showed multiple red flags for misuse -- allegations the company has denied. As part of its first bankruptcy reorganization, Rite Aid reached a settlement with the Justice Department in June 2024 resolving those allegations under the False Claims Act and Controlled Substances Act. Under the settlement, the company agreed to pay the government $7.5 million and have a general unsecured claim in Rite Aid’s bankruptcy case, which are being handled through the court process. Rite Aid did not admit to any wrongdoing. The company's second bankruptcy filing in May 2025 paused most of the remaining opioid-related lawsuits including cases brought by state and local governments as well as individual plaintiffs which are now being handled through the bankruptcy's claims process while Rite Aid works through its wind-down plan -- a plan that remains under court review amid ongoing objections from the U.S. Trustee. Rite Aid has denied the allegations in those lawsuits and in a statement in 2023 said it sought an "equitable" resolution of opioid claims through the Chapter 11 process. Founded in 1962 as Thrift D Discount Center in Scranton, Pennsylvania, Rite Aid grew into the nation's third-largest standalone pharmacy chain before its final closure. Rite Aid has ceased all operations and closed its nationwide store footprint, marking the final liquidation of the company following a second Chapter 11 bankruptcy filing in May 2025. The collapse was rapid, occurring merely eight months after the company emerged from a prior bankruptcy in September 2024, indicating the initial restructuring was insufficient to address fundamental weaknesses. The failure was driven by a combination of declining sales and the immense financial pressure from over 1,000 federal, state, and local lawsuits related to the opioid crisis. Despite a June 2024 settlement with the U.S. Department of Justice for $7.5 million, which resolved federal claims without an admission of wrongdoing, the company remained burdened by other litigation. The second bankruptcy filing, which initially aimed to facilitate an orderly asset sale with $1.94 billion in new financing, ultimately transitioned into a full wind-down, signaling the inability of the once third-largest U.S. pharmacy chain to overcome its operational and legal liabilities.

Key Decisions for Investors

• Investors should assess the market share opportunity for remaining competitors in the retail pharmacy sector, as the closure of over 1,200 Rite Aid stores creates a significant vacuum in both prescription services and front-end retail sales.
• Holders of commercial real estate assets, particularly retail REITs, must evaluate their exposure to Rite Aid leases and the subsequent impact on vacancy rates, while also considering the potential for acquiring and re-leasing these newly available properties.
• The critical role of opioid litigation in Rite Aid's failure serves as a stark reminder of legal risk; it is prudent to re-evaluate the potential financial impact of similar ongoing lawsuits for other companies in the pharmaceutical distribution and retail space.